Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1755)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4172)
  2. Weinberg Fellows (2756)
  3. Hematologic Malignancies, Division of (2492)
  4. Solid Tumor Oncology Division (2422)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (343)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Central nervous system involvement in T-cell lymphoma: A single center experience
    Meeting Abstract

    Mehta, N.; Gurion, R.; Maragulia, J.; Zelenetz, A.; Moskowitz, A.; Moskowitz, C.; Hamlin, P.; Horwitz, S.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Clinical description of acute promyelocytic leukemia (APL) patients receiving all-trans retinoic acid (ATRA) who develop pseudotumor cerebri: Incidence, diagnosis, outcomes, and recommendations for management
    Meeting Abstract

    Coombs, C. C.; DeAngelis, L. M.; Feusner, J. H.; Tallman, M. S.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Meeting Abstract

    Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
    Blood (2015)

    Fulltext@MSK | Save
  • Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma
    Meeting Abstract

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Blood (2015)

    Fulltext@MSK | Save
  • A prospective study of allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Perales, M. A.; Cho, C.; Eaton, A.; Moskowitz, A. J.; Nguyen, V.; Gonzales-Dadiz, A. M. R.; Devlin, S.; Giralt, S. A.; Jakubowski, A. A.; Matasar, M. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Successful treatment of peripheral T-cell lymphoma with allogeneic stem cell transplantation: A large single-center experience
    Meeting Abstract

    Mehta-Shah, N.; Chou, J.; Maloy, M.; Zhang, Z. G.; Moskowitz, A. J.; Moskowitz, C. H.; Barker, J. N.; Giralt, S.; Perales, M. A.; Horwitz, S. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Age-adjusted co-morbidity core - but not revised Disease Risk Index - is associated with progression-free survival after intermediate intensity double unit CBT in adults with hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Hilden, P.; Devlin, S.; Yoo, Y.; Lauer, E.; Peled, J.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Castro-Malaspina, H.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The long PD-1 receptor binding kinetics of nivolumab may increase efficacy of subsequent therapy in relapsed and refractory multiple myeloma patients
    Meeting Abstract

    Funt, S. A.; Page, D. B.; Cattry, D.; Lendvai, N.; Hassoun, H.; Landgren, O.; Borrello, I. M.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Herpes zoster is more frequent in patients receiving higher cumulative doses of arsenic trioxide and is mitigated by prophylactic acyclovir
    Meeting Abstract

    Glass, J. L.; Kishtagari, A.; Douer, D.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save